Le Temple-de-bretagne, France
Product Surveillance Registry
Phase
N/ASpan
1466 weeksSponsor
MedtronicThe Woodlands, Texas
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
All Medtronic market-released leads and all market-released IPG, ICD and CRT devices are eligible to be included in this study.
Phase
N/ASpan
3027 weeksSponsor
MedtronicThe Woodlands, Texas
Recruiting
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Phase
3Span
304 weeksSponsor
Gedeon Richter Plc.The Woodlands, Texas
Recruiting
ML-004 in Adolescents and Adults with Autism Spectrum Disorders (ASD)
Phase
2Span
220 weeksSponsor
MapLight TherapeuticsThe Woodlands, Texas
Recruiting
A Real World, Observational Registry of Chronic Wounds and Ulcers
This is a longitudinal, observational study of chronic wounds and ulcers treated at participating hospital based, outpatient wound centers. Data collection began in 2005. Structured data are collected at the point of care in the patient electronic health record and data from all patients at more than 100 wound centers in the USA and Puerto Rico are transmitted to the U.S. Wound Registry which is recognized by CMS as a Qualified Clinical Data Registry (QCDR). Participation in the USWR can satisfy the registry participation option for Stage 2 of Meaningful use. The dataset includes all wound and ulcer types such as diabetic foot ulcers, venous stasis ulcers, pressure ulcers, arterial ulcers, surgical wounds, traumatic wounds, vasculitic ulcers, arterial ulcers, sickle cell ulcers, inflammatory ulcers (e.g. pyoderma gangrenosum), and ulcers related to skin disorders such as scleroderma. Interventions provided include advanced dressings, compression bandaging, off-loading, cellular and/or tissue based therapies, hyperbaric oxygen therapy, negative pressure wound therapy, debridement, and antibiotics. Ulcers are risk stratified for outcomes reporting using the Wound Healing Index.Outcomes measured include healing or wound closure, surgical closure, death, and major and minor amputation. Data on wound care specific quality measures developed by the QCDR are also available.
Phase
N/ASpan
1100 weeksSponsor
U.S. Wound RegistryThe Woodlands, Texas
Recruiting
The Woodlands, Texas
Recruiting
The Woodlands, Texas
Recruiting
The Woodlands, Texas
Recruiting
RCT to Evaluate Social Skills in Children with Autism Using VR Technology (SoCaVR)
The purpose of this study is to find out if Floreo's VR clinical program can help with autism symptoms such as social communication skills in autistic children. Recent advances in VR technology offers a new way to improve these types of skills in children with autism in an immersive and controlled environment. Questionnaires answered by adult caregivers will be used to assess the child's behaviors during the time of treatment. Clinician observations will also be conducted as a part of this study.
Phase
N/ASpan
55 weeksSponsor
Floreo, Inc.The Woodlands, Texas
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
This is a randomized, double-blind, placebo-controlled, multicenter, 2-arm (1:1), parallel-group, efficacy and safety/tolerability fixed-dose study of SPN-812 in preschool-age children (4 to 5 years old) with ADHD. Participants will be screened for eligibility for up to 4 weeks. Eligible participants will be treated with study medication for 6 weeks. The total duration of the study is up to 10 weeks.
Phase
4Span
94 weeksSponsor
Supernus Pharmaceuticals, Inc.The Woodlands, Texas
Recruiting